Impact of captopril on the IL10 serum levels in experimental pulmonary fibrosis

M. B. B. Ben Brahim, S. M. Maalej, L. G. Gharbi, B. S. Soltani, S. Y. Yaalaoui, F. T. Tritar, S. B. K. Ben Khamsa (Tunis, Tunisia)

Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. B. B. Ben Brahim, S. M. Maalej, L. G. Gharbi, B. S. Soltani, S. Y. Yaalaoui, F. T. Tritar, S. B. K. Ben Khamsa (Tunis, Tunisia). Impact of captopril on the IL10 serum levels in experimental pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 823

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005

Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007

Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012

Correlation of HRCT proven inflammatory changes with serum levels of ACE, sIL-2r and calciuria in pulmonary sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003

Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Leptin and adiponectin levels in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018

Effect of curcumin on inflammation in experimental pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007


Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation?
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011

VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

Correlation of serum levels of matrix-metalloproteinase-9, cyclo-oxygenase-2, and prostaglandin-E-2 in Chronic obstructive pulmonary disease(COPD)
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Effect of bosentan on MMP-7 levels as add-on therapy in idiopathic pulmonary fibrosis. A prospective study
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018




Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010